Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of December 2025. The primary purpose of the report is to announce the completion of a strategic acquisition. On December 1, 2025, Cellebrite DI Ltd. finalized its acquisition of Corellium, Inc., making Corellium an indirect wholly owned subsidiary of Cellebrite.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. This document serves as a notification of a corporate event rather than a financial results report.
Material Changes
- Acquisition Completion: Cellebrite completed the merger with Corellium, Inc. pursuant to the Merger Agreement dated June 4, 2025.
- Corporate Structure: Corellium now operates as an indirect wholly owned subsidiary of Cellebrite following the merger of Merger Sub into Corellium.
- Strategic Expansion: The acquisition is intended to extend Cellebrite's AI-powered digital investigation platform capabilities.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the acquisition's completion and the strategic intent to enhance the company's digital investigation platform. The filing does not contain updated financial guidance, specific risk factors related to the integration, or details on contingencies beyond the standard incorporation of the press release into registration statements.
Key Facts for Investor Verification
- Verify the exact closing date of the Corellium acquisition (December 1, 2025).
- Review the full text of the press release (Exhibit 99.1) for details on the transaction value and consideration paid, which are not included in this summary.
- Monitor subsequent filings for the first financial impact of the Corellium acquisition on Cellebrite's consolidated results.
- Confirm the integration timeline and any potential regulatory approvals required for the combined entity.